News

It contains monounsaturated fats and omega-3s and can be a decent choice for people with non-alcoholic fatty liver disease (NAFLD)—especially when used in moderation. It is said that, when ...
Researchers at Oklahoma University found that the hormone FGF21 can reverse fatty liver disease. The hormone signals the brain to improve liver function. It lowers liver fat and reverses fibrosis.
Hepatocarcinoma is the most commonly diagnosed form of liver cancer. It is an aggressive, fast growing cancer with a 5-year ...
A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...
The research ... Research Shows How Hormone Can Reverse Fatty Liver Disease in Mice May 14, 2025 — A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21 ...
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
A new study published in Science Advances reveals that a single gene plays a big role in how the liver stores energy, a ...
studies have shown a growing link between certain liver cancers and non-viral chronic liver disease (CLD). Experts say one particular kind of liver cancer, known as hepatocellular carcinoma (HCC ...
GSK GSK1.80%increase; green up pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British ...
studies have shown a growing link between certain liver cancers and non-viral chronic liver disease (CLD). Experts say one particular kind of liver cancer, known as hepatocellular carcinoma (HCC ...
[LONDON] GSK agreed to buy an experimental medicine to treat liver disease for as much as US$2 billion as the UK drugmaker seeks to shore up its pipeline of new medicines. The treatment developed by ...